- : Ms Word Format
- : Pages
- : ₦3000
- : 1-5 Chapters
- Click to DOWNLOAD Materials
THE IMPACT OF FINTECH ON PHARMACEUTICAL COMPANY CAPITAL ALLOCATION DECISIONS.
Abstract:
The emergence of financial technology (fintech) has brought about significant changes in various industries, and the pharmaceutical sector is no exception. This study explores the impact of fintech on capital allocation decisions within pharmaceutical companies. Capital allocation decisions involve determining the most effective use of financial resources, such as investments in research and development (R&D), acquisitions, infrastructure, and other strategic initiatives.
The introduction of fintech has revolutionized the financial landscape, offering innovative tools and platforms that streamline financial processes, enhance efficiency, and provide valuable insights for decision-making. This study investigates how pharmaceutical companies have incorporated fintech solutions into their capital allocation strategies, and the subsequent effects on their overall financial performance.
The primary research objective is to understand how fintech influences decision-making processes related to capital allocation within the pharmaceutical industry. The study examines the utilization of fintech tools, such as artificial intelligence (AI)-based algorithms, data analytics, blockchain, and crowdfunding, and their impact on investment decisions.
The research methodology involves a combination of qualitative and quantitative analysis. Qualitative data will be collected through interviews and surveys with key stakeholders in pharmaceutical companies, including financial executives, investment managers, and decision-makers. The quantitative analysis will involve the examination of financial data, such as capital expenditure, R&D investments, and performance metrics, before and after the adoption of fintech solutions.
The expected outcomes of this study include identifying the specific fintech tools and platforms that have been most effective in influencing capital allocation decisions within the pharmaceutical industry. Furthermore, the study aims to uncover the challenges and opportunities associated with the adoption of fintech, including potential risks and regulatory considerations.
The findings of this research will provide valuable insights for pharmaceutical companies, financial professionals, and policymakers, enabling them to understand the implications of fintech on capital allocation decisions. The study will contribute to the existing body of knowledge on the intersection of fintech and the pharmaceutical industry, shedding light on how technology-driven innovations shape financial strategies in this sector.
Key words: Fintech, pharmaceutical industry, capital allocation decisions, research and development, financial performance, artificial intelligence, data analytics, blockchain, crowdfunding.
